Samuel J. Reich - CEO & EXECUTIVE CHAIRMAN, Director at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & EXECUTIVE CHAIRMAN, Director
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Samuel J. Reich since 12/23/2023

Holdings reported by Samuel J. Reich for SAB Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 548K $482K $0.88 Nov 29, 2023 Via Big Cypress Holdings LLC
Common Stock 219K $193K $0.88 Nov 29, 2023 Direct
Stock Option (right to buy) 35.7K Jul 15, 2024 Direct Common Stock

Transactions reported by Samuel J. Reich for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.